These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33057670)
1. Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study. Dazzan P; Lawrence AJ; Reinders AATS; Egerton A; van Haren NEM; Merritt K; Barker GJ; Perez-Iglesias R; Sendt KV; Demjaha A; Nam KW; Sommer IE; Pantelis C; Wolfgang Fleischhacker W; van Rossum IW; Galderisi S; Mucci A; Drake R; Lewis S; Weiser M; Martinez Diaz-Caneja CM; Janssen J; Diaz-Marsa M; Rodríguez-Jimenez R; Arango C; Baandrup L; Broberg B; Rostrup E; Ebdrup BH; Glenthøj B; Kahn RS; McGuire P; Schizophr Bull; 2021 Mar; 47(2):444-455. PubMed ID: 33057670 [TBL] [Abstract][Full Text] [Related]
2. Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses. Ajnakina O; Das T; Lally J; Di Forti M; Pariante CM; Marques TR; Mondelli V; David AS; Murray RM; Palaniyappan L; Dazzan P Schizophr Bull; 2021 Oct; 47(6):1729-1739. PubMed ID: 33851203 [TBL] [Abstract][Full Text] [Related]
3. Cortical folding defects as markers of poor treatment response in first-episode psychosis. Palaniyappan L; Marques TR; Taylor H; Handley R; Mondelli V; Bonaccorso S; Giordano A; McQueen G; DiForti M; Simmons A; David AS; Pariante CM; Murray RM; Dazzan P JAMA Psychiatry; 2013 Oct; 70(10):1031-40. PubMed ID: 23945954 [TBL] [Abstract][Full Text] [Related]
4. Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial. Voineskos AN; Mulsant BH; Dickie EW; Neufeld NH; Rothschild AJ; Whyte EM; Meyers BS; Alexopoulos GS; Hoptman MJ; Lerch JP; Flint AJ JAMA Psychiatry; 2020 Jul; 77(7):674-683. PubMed ID: 32101271 [TBL] [Abstract][Full Text] [Related]
5. No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis. Haukvik UK; Hartberg CB; Nerland S; Jørgensen KN; Lange EH; Simonsen C; Nesvåg R; Dale AM; Andreassen OA; Melle I; Agartz I Psychol Med; 2016 Feb; 46(3):589-98. PubMed ID: 26526001 [TBL] [Abstract][Full Text] [Related]
6. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856 [TBL] [Abstract][Full Text] [Related]
7. Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial. Chopra S; Francey SM; O'Donoghue B; Sabaroedin K; Arnatkeviciute A; Cropley V; Nelson B; Graham J; Baldwin L; Tahtalian S; Yuen HP; Allott K; Alvarez-Jimenez M; Harrigan S; Pantelis C; Wood SJ; McGorry P; Fornito A JAMA Psychiatry; 2021 Sep; 78(9):994-1004. PubMed ID: 34160595 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotics Effects on Network-Level Reconfiguration of Cortical Morphometry in First-Episode Schizophrenia. Jiang Y; Wang Y; Huang H; He H; Tang Y; Su W; Xu L; Wei Y; Zhang T; Hu H; Wang J; Yao D; Wang J; Luo C Schizophr Bull; 2022 Jan; 48(1):231-240. PubMed ID: 34313782 [TBL] [Abstract][Full Text] [Related]
9. Anterior Hippocampal-Cortical Functional Connectivity Distinguishes Antipsychotic Naïve First-Episode Psychosis Patients From Controls and May Predict Response to Second-Generation Antipsychotic Treatment. Blessing EM; Murty VP; Zeng B; Wang J; Davachi L; Goff DC Schizophr Bull; 2020 Apr; 46(3):680-689. PubMed ID: 31433843 [TBL] [Abstract][Full Text] [Related]
10. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study. Del Re EC; Stone WS; Bouix S; Seitz J; Zeng V; Guliano A; Somes N; Zhang T; Reid B; Lyall A; Lyons M; Li H; Whitfield-Gabrieli S; Keshavan M; Seidman LJ; McCarley RW; Wang J; Tang Y; Shenton ME; Niznikiewicz MA Schizophr Bull; 2021 Mar; 47(2):562-574. PubMed ID: 32926141 [TBL] [Abstract][Full Text] [Related]
11. Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia. Takeuchi H; Siu C; Remington G; Fervaha G; Zipursky RB; Foussias G; Agid O Neuropsychopharmacology; 2019 May; 44(6):1036-1042. PubMed ID: 30514883 [TBL] [Abstract][Full Text] [Related]
12. Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study. Kraguljac NV; White DM; Hadley N; Hadley JA; Ver Hoef L; Davis E; Lahti AC Schizophr Bull; 2016 Jul; 42(4):1046-55. PubMed ID: 26873890 [TBL] [Abstract][Full Text] [Related]
13. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579 [TBL] [Abstract][Full Text] [Related]
14. Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment. Emsley R; Asmal L; du Plessis S; Chiliza B; Phahladira L; Kilian S Psychol Med; 2017 Sep; 47(12):2187-2196. PubMed ID: 28347393 [TBL] [Abstract][Full Text] [Related]